Copy Link Print Information

Girentuximab

(Synonyms: G250; cG250)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC).

For research use only. We do not sell to patients.

  • Purity: 99.90%
  • CAS No.: 916138-87-9
  • Molecular Weight:144.62 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Girentuximab
  • Experimental Validation Results for Girentuximab
  • Experimental Validation Results for Girentuximab
  • Girentuximab Chemical Structure
    Girentuximab Chemical Structure
CAS No.: 916138-87-9
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Girentuximab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Girentuximab

More

All Carbonic Anhydrase Isoforms

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized Carbonic Anhydrase 9 Protein, Canine (HEK293, His, HY-P75454) can bind Girentuximab. The EC50 for this effect is 26.65 ng/mL.

  • 1/16

    Flow cytometric analysis of 1.5×106 HT-29 cells with Girentuximab (HY-P99023, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control.

  • Girentuximab Chemical Structure
    1/16
  • Girentuximab
  • Immobilized Carbonic Anhydrase 9 Protein, Canine (HEK293, His, HY-P75454) can bind Girentuximab. The EC50 for this effect is 26.65 ng/mL.
  • Flow cytometric analysis of 1.5×106 HT-29 cells with Girentuximab (HY-P99023, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control.